1.Rapid Determination of Paraquat and Diquat Residues in Tea by QuEChERS/Ultra-High Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
Yan-Hua TANG ; Ying-Nan GAO ; Jiang-Yan CHEN ; Xin-Yi GUO ; Shao-Yong LI ; Yue LI ; Zhen ZHOU ; Wei GAO
Chinese Journal of Analytical Chemistry 2024;52(10):1619-1627
A rapid analytical method for determination of paraquat and diquat in tea samples was established by improving the QuEChERS pre-treatment method combined with ultra-high performance liquid chromatography-tandem quadrupole mass spectrometry(UPLC-MS/MS).Four kinds of tea powder were extracted by using acetonitrile-0.1%formic acid solution(3∶7,V/V)and ultrasonic treatment,and the supernatant was purified with 400 mg C18 and 400 mg PSA and separated on hydrophilic HILIC(100 mm×2.1 mm,1.8 μm)column by using 0.1%formic acid aqueous solution(Containing 5 mmol/L ammonium formate)and acetonitrile as mobile phases.In the electrospray ion source positive ion mode(ESI+),multiple reaction monitoring scanning technology(MRM)was used for determination,and the matrix-matched standard solution external standard method was used for quantitative analysis.The results showed that paraquat obtained good linear relationship in the content range of 0.18-200 μg/kg and diquat obtained good linear relationship in the content range of 0.36-200 μg/kg,and the correlation coefficients(R2)were 0.9939-0.9976 and 0.9959-0.9987,respectively.The limits of detection(LODs)were 0.06 and 0.12 μg/kg,and the limits of quantitation(LOQs)were 0.18 and 0.36 μg/kg,respectively.The average spiked recoveries for tea samples varied from 84.4%to 128.8%,with the relative standard deviations(RSDs)from 0.6%to 13.5%.The method was simple and efficient,with accurate quantification ability and low detection limit,which could realize efficient determination of paraquat and diquat in tea samples.
2.Expert consensus on the prevention and treatment of adverse reactions in subcutaneous immunotherapy(2023, Chongqing).
Yu Cheng YANG ; Yang SHEN ; Xiang Dong WANG ; Yan JIANG ; Qian Hui QIU ; Jian LI ; Shao Qing YU ; Xia KE ; Feng LIU ; Yuan Teng XU ; Hong Fei LOU ; Hong Tian WANG ; Guo Dong YU ; Rui XU ; Juan MENG ; Cui Da MENG ; Na SUN ; Jian Jun CHEN ; Ming ZENG ; Zhi Hai XIE ; Yue Qi SUN ; Jun TANG ; Ke Qing ZHAO ; Wei Tian ZHANG ; Zhao Hui SHI ; Cheng Li XU ; Yan Li YANG ; Mei Ping LU ; Hui Ping YE ; Xin WEI ; Bin SUN ; Yun Fang AN ; Ya Nan SUN ; Yu Rong GU ; Tian Hong ZHANG ; Luo BA ; Qin Tai YANG ; Jing YE ; Yu XU ; Hua Bin LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2023;58(7):643-656
3.Genetic Subtypes and Pretreatment Drug Resistance in the Newly Reported Human Immunodeficiency Virus-Infected Men Aged≥50 Years Old in Guangxi.
Ning-Ye FANG ; Wen-Cui WEI ; Jian-Jun LI ; Ping CEN ; Xian-Xiang FENG ; Dong YANG ; Kai-Ling TANG ; Shu-Jia LIANG ; Yu-Lan SHAO ; Hua-Xiang LU ; He JIANG ; Qin MENG ; Shuai-Feng LIU ; Qiu-Ying ZHU ; Huan-Huan CHEN ; Guang-Hua LAN ; Shi-Xiong YANG ; Li-Fang ZHOU ; Jing-Lin MO ; Xian-Min GE
Acta Academiae Medicinae Sinicae 2023;45(3):399-404
Objective To analyze the genetic subtypes of human immunodeficiency virus (HIV) and the prevalence of pretreatment drug resistance in the newly reported HIV-infected men in Guangxi. Methods The stratified random sampling method was employed to select the newly reported HIV-infected men aged≥50 years old in 14 cities of Guangxi from January to June in 2020.The pol gene of HIV-1 was amplified by nested reverse transcription polymerase chain reaction and then sequenced.The mutation sites associated with drug resistance and the degree of drug resistance were then analyzed. Results A total of 615 HIV-infected men were included in the study.The genetic subtypes of CRF01_AE,CRF07_BC,and CRF08_BC accounted for 57.4% (353/615),17.1% (105/615),and 22.4% (138/615),respectively.The mutations associated with the resistance to nucleoside reverse transcriptase inhibitors (NRTI),non-nucleoside reverse transcriptase inhibitors (NNRTI),and protease inhibitors occurred in 8 (1.3%),18 (2.9%),and 0 patients,respectively.M184V (0.7%) and K103N (1.8%) were the mutations with the highest occurrence rates for the resistance to NRTIs and NNRTIs,respectively.Twenty-two (3.6%) patients were resistant to at least one type of inhibitors.Specifically,4 (0.7%),14 (2.3%),4 (0.7%),and 0 patients were resistant to NRTIs,NNRTIs,both NRTIs and NNRTIs,and protease inhibitors,respectively.The pretreatment resistance to NNRTIs had much higher frequency than that to NRTIs (2.9% vs.1.3%;χ2=3.929,P=0.047).The prevalence of pretreatment resistance to lamivudine,zidovudine,tenofovir,abacavir,rilpivirine,efavirenz,nevirapine,and lopinavir/ritonavir was 0.8%, 0.3%, 0.7%, 1.0%, 1.3%, 2.8%, 2.9%, and 0, respectively. Conclusions CRF01_AE,CRF07_BC,and CRF08_BC are the three major strains of HIV-infected men≥50 years old newly reported in Guangxi,2020,and the pretreatment drug resistance demonstrates low prevalence.
Male
;
Humans
;
Middle Aged
;
Reverse Transcriptase Inhibitors/therapeutic use*
;
HIV Infections/drug therapy*
;
Drug Resistance, Viral/genetics*
;
China/epidemiology*
;
Mutation
;
HIV-1/genetics*
;
Protease Inhibitors/therapeutic use*
;
Genotype
4.Controlled release and cytobiology of recombinant human parathyroid hormone 1-34 mediated by hyaluronic acid thermo-sensitive hydrogels
Shao-yan XUAN ; Yue ZHU ; Lin ZHANG ; Zhi-hua TANG ; Feng XU ; Teng CHEN ; Zu-hua WANG
Acta Pharmaceutica Sinica 2022;57(3):809-817
The bone formation promoter recombinant human parathyroid hormone 1-34 [PTH (1-34)] has a short half-life and low bioavailability. In this study, we prepared a biodegradable and temperature-sensitive hyaluronic acid-poly-
5.Comparative Performance of Four Creatinine-based GFR Estimating Equations
Pei-jia LIU ; Hong-quan PENG ; Xing-hua GUO ; Lei-le TANG ; Shao-min LI ; Jia FANG ; Xun LIU
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(4):621-630
ObjectiveTo assess the predictive performance of four creatinine-based equations for estimated glomerular filtration rate (eGFR): 2012 chronic kidney disease epidemiology collaboration (CKD-EPIcr) equation , 2021CKD-EPIcr equation, Xiangya equation and European kidney function consortium (EKFC) equation. MethodsA total of 198 patients with chronic kidney disease from the Third Affiliated Hospital of Sun Yat-sen University and the Kiang Wu Hospital in Macau were enrolled. We compared the GFR measured (mGFR) by iohexol plasma clearance and the eGFR calculated by four equations. The agreement between mGFR and eGFR was analyzed by Bland-Altman plots, concordance correlation coefficient (CCC), coverage probability (CP) and total deviation index (TDI). The performance of eGFR equations, including their bias, precision, root square mean error (RSME), and percentage of estimates within 30% deviation of measured GFR (P30), were evaluated. Bootstrap method (2 000 samples) was used to calculate bias, interquartile range (IQR), RSME, and 95% confidence intervals (CI) for P30. After selecting the optimal eGFR equation as the reference, we statisticlly tested other equations by ① Wilcoxon signed-rank test for bias; ② McNemar-Bowker test for P30; ③ comparing RMSE and IQR with independent samples t test after 2 000 bootstrap samples were obtained. ResultsThe median mGFR and four eGFR equations (EKFC, 2012CKD-EPIcr, 2021CKD-EPIcr and Xiangya equation) in the overall population were 56.2 mL·min-1·(1.73m2)-1, 67.1 mL·min-1·(1.73m2)-1, 73.0 mL·min-1·(1.73m2)-1, 66.9 mL·min-1·(1.73m2)-1 and 63.8 mL·min-1·(1.73m2)-1, respectively. The Bland-Altman plots showed that EKFC equation had the lowest mean difference and the narrowest 95% limit of agreement. The EKFC equation had the optimal performance on CCC, TDI and CP with values of 0.90, 24.41 and 0.50, respectively. Overall, the bias, accuracy, P30 and RSME from the EKFC equation was -0.99, 14.64, 0.80, and 14.68, respectively, with 95% CI ranging from -2.53 to 0.94, 11.82 to 17.35, 0.73 to 0.85, and 12.69 to 17.35, respectively, which were superior to those values from other three eGFR equations. The differences were statistically significant (all P < 0.05). The results in the mGFR subgroups were basically consistent with the overall trend. ConclusionsOf the four eGFR equations validated in this study, the EKFC equation comprehensively surpasses 2012CKD-EPIcr equation, 2021CKD-EPIcr equation, and Xiangya equation. With P30>75%, the EKFC equation can meet clinical diagnostic needs. Therefore, the EKFC equation is recommended for estimating GFR in a Chinese population, but more participants need be included to further support this conclusion.
6.Predictive Effect of High Density Lipoprotein to C-reactive Protein Ratio on Progression of Chronic Kidney Disease in Non-Dialysis Patient
Lei-le TANG ; Xing-hua GUO ; Shao-min LI ; Pei-jia LIU ; Jia FANG ; Xun LIU
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(2):305-315
ObjectiveTo investigate the predictive effect of high density lipoprotein (HDL) to C-reactive protein (CRP) ratio (HDL/CRP) on the progression of chronic kidney disease (CKD) in non-dialysis patients. MethodsNon-dialysis chronic kidney disease patients with at least two sets of follow-up data from the Third Affiliated Hospital of Sun Yat-sen University (Tian-he and Ling-nan districts)from 2015 to 2019 were enrolled. The baseline demographic characteristics and biochemical examination results were collected from the electronic medical record system. The patients were grouped according to the quantile of Ln(HDL/CRP). The demographic and biochemical data were compared among groups by one-way ANOVA for normal distribution continuous variables, Kruskal-Wallis rank-sum test for non-normal distribution continuous variables, and Chi-square analysis for categorical variables. The relationship between HDL/CRP and baseline eGFR was investigated by correlation analysis, univariate and multivariate linear regression analysis. The Cox survival analysis were used to investigate the predictive effect of Ln(HDL/CRP) on renal deterioration events. ResultsTotally 9 142 patients with CKD were enrolled, and 439 patients were included in the end. There were 100 patients (22.8%) with chronic glomerulonephritis, 145 patients (33%) with diabetic nephropathy, 40 patients (9.1%) with hypertensive nephropathy, and 154 patients (35.1%) with other causes. According to Ln(HDL/CRP) quartile, group Quartile4 had a lower incidence of renal deterioration than the other three groups (11% vs. 21.1% to 21.8%) and had the highest baseline eGFR level. From Quartile1 to quartile 4 groups, age, Hba1c and APOA1 levels decreased gradually. The prevalence of chronic heart failure, BMI, hemoglobin, albumin, TC, LDL, TG, APOB100 levels were different among groups. Through correlation analysis, Ln (HDL/CRP) were positively correlated with baseline eGFR(r=0.162, P=0.001). After adjusting for a variety of factors by Cox regression analysis, Ln (HDL/CRP) could be included in the final equation when defined deterioration of renal function as end point [HR=0.79, 95%CI (0.69, 0.91), P=0.001]. ConclusionHDL/CRP can reflect the severity of chronic kidney disease, and the ratio of HDL and CRP can predict the progression of chronic kidney disease in non-dialysis patient.
7.Interventional effect of asiaticosdide on rats exposed to silica dust.
Chen XING ; Zhi Feng YANG ; Cun Xiang BO ; Qiong TANG ; Qiang JIA ; Zhen Ling ZHANG ; Hua SHAO
Chinese Journal of Industrial Hygiene and Occupational Diseases 2022;40(1):12-17
Objective: To investigate the effect of asiaticoside for fibrosis in lung tissues of rats exposed to silica and to explore its possible mechanism. Methods: 144 SD male rats were randomly divided into control group, model group, positive drug control group, asiaticoside high-dose group, medium-dose group and low-dose group, each group included 24 rats. Rats in the control group were perfused with 1.0 ml of normal saline, and the other groups were given 1.0 ml 50 mg/ml SiO(2) suspension. Gavage of herbal was given from the next day after model establishment, once a day. Rats in the positive drug control group were administration with 30 mg/kg tetrandrine and rats in the low-dose group, medium-dose group and high-dose group were given 20 mg/kg, 40 mg/kg and 60 mg/kg asiaticoside for fibrosis respectively. Rats in the control group and the model group were given 0.9% normal saline. The rats were sacrificed in on the 14th, 28th and 56th day after intragastric administration and collect the lung tissues to detect the content of hydroxyproline, TGF-β(1) and IL-18, observe the pathological changes of the lung tissues by HE and Masson staining and determine the expressions of Col-I, a-SMA, TGF-β in lung tissues by Western Blot. Results: On the 14th day, 28th day and 56th day after model establishment, the lung tissues of rats in the model group showed obvious inflammatory response and accumulation of collagen fibers, and the degree of inflammation and fibrosis increased with time. The intervention of asiaticoside could effectively inhibit the pathological changes of lung tissues. The contents of hydroxyproline, IL-18 and TGF-β1 in lung tissues of model group were higher than those in the control group (P<0.05) , while the level of hydroxyproline, IL-18 and TGF-β1 in asiaticoside groups were significantly decreased, and the difference was statistically signicant (P<0.05) . Compared with the control group, the expression levels of Col-I, TGF-β1and α-SMA in lung tissue of model group were increased (P<0.05) , while the expression level of Col-I, TGF-β1 and α-SMA were decreased after the intervention of asiaticoside, and the difference was statistically signicant (P<0.05) . Conclusion: Asiaticoside can inhibit the increase of Col-I, TGF-β1 and α-SMA content in the SiO(2)-induced lung tissues of rats, reduce the release of TGF-β1 and IL-18 inflammatory factors in lung tissue, and then inhibit the synthesis and deposition of extracellular matrix in rat lung tissue, and improve silicosis fibrosis.
Animals
;
Dust
;
Lung
;
Male
;
Pulmonary Fibrosis/metabolism*
;
Rats
;
Silicon Dioxide/adverse effects*
;
Silicosis/metabolism*
;
Transforming Growth Factor beta1/metabolism*
8.Characterization of Changes and Driver Microbes in Gut Microbiota During Healthy Aging Using A Captive Monkey Model
Wei ZHI-YUAN ; Rao JUN-HUA ; Tang MING-TIAN ; Zhao GUO-AN ; Li QI-CHUN ; Wu LI-MING ; Liu SHAO-QIANG ; Li BI-HAI ; Xiao BAI-QUAN ; Liu XING-YIN ; Chen JIAN-HUAN
Genomics, Proteomics & Bioinformatics 2022;20(2):350-365
Recent population studies have significantly advanced our understanding of how age shapes the gut microbiota.However,the actual role of age could be inevitably confounded due to the complex and variable environmental factors in human populations.A well-controlled envi-ronment is thus necessary to reduce undesirable confounding effects,and recapitulate age-dependent changes in the gut microbiota of healthy primates.Herein we performed 16S rRNA gene sequenc-ing,characterized the age-associated gut microbial profiles from infant to elderly crab-eating maca-ques reared in captivity,and systemically revealed the lifelong dynamic changes of the primate gut microbiota.While the most significant age-associated taxa were mainly found as commensals such as Faecalibacterium,the abundance of a group of suspicious pathogens such as Helicobacter was exclusively increased in infants,underlining their potential role in host development.Importantly,topology analysis indicated that the network connectivity of gut microbiota was even more age-dependent than taxonomic diversity,and its tremendous decline with age could probably be linked to healthy aging.Moreover,we identified key driver microbes responsible for such age-dependent network changes,which were further linked to altered metabolic functions of lipids,carbohydrates,and amino acids,as well as phenotypes in the microbial community.The current study thus demon-strates the lifelong age-dependent changes and their driver microbes in the primate gut microbiota,and provides new insights into their roles in the development and healthy aging of their hosts.
9.Effect of Jianpi Bushen Sequential Formula on Adjuvant Chemotherapy of Colon Cancer: Study Protocol for a Randomized Controlled Trial.
Tong ZHANG ; Yu-Tong FEI ; Yun XU ; Ling-Yun SUN ; Bin HE ; Shao-Hua YAN ; Mo TANG ; Yun-Zi YAN ; Jun MAO ; Yu-Fei YANG
Chinese journal of integrative medicine 2021;27(12):891-895
BACKGROUND:
The side effects of chemotherapy-induced nausea and vomiting (CINV) and myelosuppression reduce the cancer patients' adherence to chemotherapy. Many Chinese patients choose Chinese medicine (CM) during chemotherapy to reduce side effects; however, the evidence is lacking. The efficacy of a CM herbal treatment protocol, Jianpi Bushen Sequential Formula (, JBSF) will be evaluated on chemotherapy completion rate among patients with colon cancer.
METHODS:
A multi-center double-blind randomized controlled trial (RCT) will be conducted on 400 patients with colon cancer who will receive 8 cycles of adjuvant chemotherapy with oxaliplatin and capecitabine (CAPEOX). Patients will be randomized 1:1 to receive the JBSF or placebo formula. The primary outcome is the overall chemotherapy completion rate. The secondary outcomes include individual chemotherapy completion rate, 4-cycle completion rate of chemotherapy, time to treatment failure, relative dose intensity and treatment toxicity. Follow-up visits will be scheduled before every and after last chemotherapy.
DISCUSSION
This study will provide evidence on whether JBSF can improve the chemotherapy completion rate and reduce side effects among patients with colon cancer. (Trial registration: ClinicalTrials.gov, No. NCT03716518).
Chemotherapy, Adjuvant
;
Colonic Neoplasms/drug therapy*
;
Double-Blind Method
;
Humans
;
Multicenter Studies as Topic
;
Nausea
;
Quality of Life
;
Randomized Controlled Trials as Topic
;
Treatment Outcome
;
Vomiting
10.China experts' consensus on preventive and interceptive orthodontic treatments of malocclusions of children.
Xiao-Bing LI ; Quan-Fu YE ; Hong HE ; Hai-Ping LU ; Min ZHU ; Ruo-Ping JIANG ; Shu-Juan ZOU ; Xiang-Long HAN ; Li ZHOU ; Ke CHEN ; Xiao YUAN ; Jun-Mei ZHANG ; Li-Jun TAN ; Chang YIN ; Zhou HE ; Ang LI ; Bin CHENG ; Wen-Hua RUAN ; Fang HUANG ; Juan LIU ; Lan MA ; Rui ZOU ; Fang YANG ; Wei-Bing ZHANG ; Yu-Lou TIAN ; Bei-Zhan JIANG ; Lin-Qin SHAO ; Yang HUANG ; Li-Qin TANG ; Li GAO ; Chen-Chen ZHOU
West China Journal of Stomatology 2021;39(4):369-376
Malocclusion is one of the three most common oral diseases reported by World Health Organization(WHO). In China, its incidence rate is rising. Malocclusion seriously affects the dental and maxillofacial function, facial appearance and growth development of nearly 260 million children in China, and what is more, it affects their physical and mental health development. Malocclusion occurrence is related to genetic and environmental factors. Early treatment of malocclusion can create a good dental and maxillofacial development environment, correct abnormal growth and control the adverse effects of abnormal genetic factors. It can effectively reduce the prevalence of children's malocclusion and enhance their physical and mental health. This is an urgent need from the economic perspective of our society, so it has great practical and social significance. Experts from the project group "standard diagnose and treatment protocols for early orthodontic intervention of malocclusions of children" which initiated by China National Health Institute of Hospital Administration wrote the "China Experts' Consensus on Preventive and Interceptive Orthodontic Treatments of Malocclusions of Children", which aims to guide and popularize the clinical practice, improve the clinical theory and practice level, and accelerate the disciplinary development of early treatment of children's malocclusion in China. The consensus elaborates the harmfulness of malocclusion and the necessity of early treatment, and brings up the principles and fundamental contents. Based on the law of dental and maxillofacial development, this paper puts forward the guiding suggestions of preventive and interceptive treatments in different stages of dental development ranging from fetus to early permanent dentition. It is a systematic project to promote and standardize the early treatment of malocclusion. Through scientific and comprehensive stratified clinical practice and professional training, the clinical system of early treatment of malocclusion in China will eventually be perfected, so as to comprehensively care for children's dental and maxillofacial health, and improve their oral and physical health in China.
Child
;
China/epidemiology*
;
Consensus
;
Dental Care
;
Humans
;
Malocclusion/prevention & control*
;
Orthodontics, Interceptive

Result Analysis
Print
Save
E-mail